Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease

Autor(es):Mostrar menos -

Salsoso, Rocio ; Dalcoquio, Talia F. ; Furtado, Remo H. M. ; Franci, Andre ; Barbosa, Carlos J. D. G. ; Genestreti, Paulo R. R. ; Strunz, Celia M. C. ; Lima, Viviane ; Baracioli, Luciano M. ; Giugliano, Robert P. ; Goodman, Shaun G. ; Gurbel, Paul A. ; Maranhao, Raul C. ; Nicolau, Jose C.

• Tipo de documento: Artigo Científico
• Fonte: ADVANCES IN THERAPY; v. 37, n. 11, p. 17-pg., 2020-09-05.

Resumo

Introduction Lipoprotein (a) [Lp(a)] is a risk factor for coronary artery disease (CAD). To the best of our knowledge, this is the first study addressing the relationship between Lp(a) and platelet reactivity in primary and secondary prevention. Methods Lp(a) was evaluated in 396 individuals with (82.3%) and without (17.7%) obstructive CAD. The population was divided into two groups according to Lp(a) concentrations with a cutoff value of 50 mg/dL. The primary objective was to evaluate the association between Lp(a) and adenosine diphosphate (ADP)-induced platelet reactivity using the VerifyNow (TM) P2Y(12)assay. Platelet reactivity was also induced by arachidonic acid and collagen-epinephrine (C-EPI) and assessed by Multiplate (TM), platelet function analyzer (TM) 100 (PFA-100), and light transmission aggregometry (LTA) assays. Secondary objectives included the assessment of the primary endpoint in individuals with or without CAD. Results Overall, 294 (74.2%) individuals had Lp(a) < 50 mg/dL [median (IQR) 13.2 (5.8-27.9) mg/dL] and 102 (25.8%) had Lp(a) >= 50 mg/dL [82.5 (67.6-114.5) mg/dL],P < 0.001. Univariate analysis in the entire population revealed no differences in ADP-induced platelet reactivity between individuals with Lp(a) >= 50 mg/dL (249.4 +/- 43.8 PRU) versus Lp(a) < 50 mg/dL (243.1 +/- 52.2 PRU),P = 0.277. Similar findings were present in individuals with (P = 0.228) and without (P = 0.669) CAD, and regardless of the agonist used or method of analysis (allP > 0.05). Finally, multivariable analysis did not show a significant association between ADP-induced platelet reactivity and Lp(a) >= 50 mg/dL [adjusted OR = 1.00 [(95% CI 0.99-1.01),P = 0.590]. Conclusion In individuals with or without CAD, Lp(a) >= 50 mg/dL was not associated with higher platelet reactivity. (AU)

• Processo FAPESP: 14/03742-0 - Projeto temático em medicina translacional: nanopartículas que se ligam a receptores de lipoproteínas no tratamento da aterosclerose, do infarto agudo de miocárdio, do pós-transplante de coração, do câncer e da endometriose
• Beneficiário: Raul Cavalcante Maranhao
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 17/26922-2 - A importância da agregação plaquetária nas diferentes formas de apresentação da Doença Arterial Coronária: da Aterosclerose subclínica às Síndromes Isquêmicas Miocárdicas Instáveis
• Beneficiário: María Del Rocío Salsoso Rodríguez
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 14/01021-4 - Agregação e antiagregação plaquetária em pacientes com doença arterial coronária
• Beneficiário: José Carlos Nicolau
• Modalidade de apoio: Auxílio à Pesquisa - Temático